Xigen is developing innovative therapeutic peptides for a broad range of diseases with underserved medical needs and proven commercial value, with a focus on inflammation. Xigen’s technology platform enables the design and synthesis of cell-penetrating peptides with enhanced metabolic stability, using proprietary carrier motifs to selectively deliver them to intracellular targets.
 
   
PRODUCTS overview
Xigen's strategy is to identify
important control elements (hubs)
for major debilitating diseases...
Partnerships
Xigen is involved in
partnering activities...
TECHNOLOGY overview
Xigen relies for its drugs on its intracellular
Peptide Transporter technology (ICPTTM)...
Pipeline - Xigen is building a pipelineof specific, persistent, intracellular inhibitory peptides...
 
Web creation : Alchimie